Cargando…

Human Anti-Oxidation Protein A1M—A Potential Kidney Protection Agent in Peptide Receptor Radionuclide Therapy

Peptide receptor radionuclide therapy (PRRT) has been in clinical use for 15 years to treat metastatic neuroendocrine tumors. PRRT is limited by reabsorption and retention of the administered radiolabeled somatostatin analogues in the proximal tubule. Consequently, it is essential to develop and emp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahlstedt, Jonas, Tran, Thuy A., Strand, Sven-Erik, Gram, Magnus, Åkerström, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691176/ https://www.ncbi.nlm.nih.gov/pubmed/26694383 http://dx.doi.org/10.3390/ijms161226234

Ejemplares similares

Kidney Protection with the Radical Scavenger α(1)-Microglobulin (A1M) during Peptide Receptor Radionuclide and Radioligand Therapy
por: Kristiansson, Amanda, et al.
Publicado: (2021)

Protection of Kidney Function with Human Antioxidation Protein α(1)-Microglobulin in a Mouse (177)Lu-DOTATATE Radiation Therapy Model
por: Kristiansson, Amanda, et al.
Publicado: (2019)

(177)Lu-PSMA-617 Therapy in Mice, with or without the Antioxidant α(1)-Microglobulin (A1M), Including Kidney Damage Assessment Using (99m)Tc-MAG3 Imaging
por: Kristiansson, Amanda, et al.
Publicado: (2021)

Recombinant α(1)-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a (177)Lu-DOTATATE Mouse Radiation Model
por: Alattar, Abdul Ghani, et al.
Publicado: (2023)

rA1M-035, a Physicochemically Improved Human Recombinant α(1)-Microglobulin, Has Therapeutic Effects in Rhabdomyolysis-Induced Acute Kidney Injury
por: Åkerström, Bo, et al.
Publicado: (2019)

Editorial: Biomarkers of Oxidative Stress
por: Gram, Magnus, et al.
Publicado: (2020)

Structure, Functions, and Physiological Roles of the Lipocalin α(1)-Microglobulin (A1M)
por: Bergwik, Jesper, et al.
Publicado: (2021)

α(1)-Microglobulin (A1M) Protects Human Proximal Tubule Epithelial Cells from Heme-Induced Damage In Vitro
por: Kristiansson, Amanda, et al.
Publicado: (2020)

α(1)-Microglobulin Protects Against Bleeding-Induced Oxidative Damage in Knee Arthropathies
por: Larsson, Staffan, et al.
Publicado: (2018)

Peptide Receptor Radionuclide Therapy
por: Hofland, Johannes, et al.
Publicado: (2022)

The Role of α(1)-Microglobulin (A1M) in Erythropoiesis and Erythrocyte Homeostasis—Therapeutic Opportunities in Hemolytic Conditions
por: Kristiansson, Amanda, et al.
Publicado: (2020)

A1M Ameliorates Preeclampsia-Like Symptoms in Placenta and Kidney Induced by Cell-Free Fetal Hemoglobin in Rabbit
por: Nääv, Åsa, et al.
Publicado: (2015)

Nutraceuticals as Potential Radionuclide Decorporation Agents
por: Vergara, Vernieda B., et al.
Publicado: (2021)

The heme and radical scavenger α(1)-microglobulin (A1M) confers early protection of the immature brain following preterm intraventricular hemorrhage
por: Romantsik, Olga, et al.
Publicado: (2019)

Protection of the patient in radionuclide investigation
por: Commission Internationale de Protection contre les Radiations
Publicado: (1971)

Simplified dosimetry for kidneys and tumors in (177)Lu-labeled peptide receptor radionuclide therapy
por: Ardenfors, Oscar, et al.
Publicado: (2022)

Hematological Toxicity in Mice after High Activity Injections of (177)Lu-PSMA-617
por: Kristiansson, Amanda, et al.
Publicado: (2022)

An indium-111-labelled membrane-targeted peptide for cell tracking with radionuclide imaging
por: Pruller, Johanna, et al.
Publicado: (2022)

Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022)

Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics
por: Chakraborty, Kushal, et al.
Publicado: (2023)

Improved Quality of Life in Patients Treated with Peptide Radionuclides
por: Traub-Weidinger, T, et al.
Publicado: (2011)

The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas
por: Fodi, Christina-Katharina, et al.
Publicado: (2022)

Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements
por: Merola, Elettra, et al.
Publicado: (2023)

The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators
por: Gram, Magnus, et al.
Publicado: (2015)

Correction: The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators
por: Gram, Magnus, et al.
Publicado: (2020)

Radiation protection dosimetry: radionuclides and radiation protection data handbook
por: Nucl. Techn. Publ.
Publicado: (2002)

Hemoglobin induces inflammation after preterm intraventricular hemorrhage by methemoglobin formation
por: Gram, Magnus, et al.
Publicado: (2013)

In Vitro comparison of (213)Bi- and (177)Lu-radiation for peptide receptor radionuclide therapy
por: Chan, Ho Sze, et al.
Publicado: (2017)

In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib
por: Feijtel, Danny, et al.
Publicado: (2023)

Potentiation of Peptide Receptor Radionuclide Therapy by the PARP Inhibitor Olaparib
por: Nonnekens, Julie, et al.
Publicado: (2016)

Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor
por: Häfliger, Simon, et al.
Publicado: (2020)

Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview
por: Cimini, Andrea, et al.
Publicado: (2021)

Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward
por: Feijtel, Danny, et al.
Publicado: (2020)

The Effects of Peptide Receptor Radionuclide Therapy on the Neoplastic and Normal Pituitary
por: Marques, Pedro
Publicado: (2023)

Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties
por: Miranda, Ana Cláudia Camargo, et al.
Publicado: (2021)

Dapagliflozin stimulates glucagon secretion at high glucose: experiments and mathematical simulations of human A-cells
por: Pedersen, Morten Gram, et al.
Publicado: (2016)

Co-administration with A1M does not influence apoptotic response of (177)Lu-octreotate in GOT1 neuroendocrine tumors
por: Rassol, Nishte, et al.
Publicado: (2023)

Extracellular hemoglobin - mediator of inflammation and cell death in the choroid plexus following preterm intraventricular hemorrhage
por: Gram, Magnus, et al.
Publicado: (2014)

A1M/α(1)-Microglobulin Protects from Heme-Induced Placental and Renal Damage in a Pregnant Sheep Model of Preeclampsia
por: Wester-Rosenlöf, Lena, et al.
Publicado: (2014)

Peptide Receptor Radionuclide Therapy of Differentiated Thyroid Cancer: Efficacy and Toxicity
por: Czepczyński, Rafał, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s3e0qj9odlms8r3v1idja0st20